Evaluation of transmission-blocking potential of Pv22 using clinical Plasmodium vivax infections and transgenic Plasmodium berghei
Antigens expressed during the sexual development of malaria parasites are transmission-blocking vaccine (TBV) targets. Pb22, a protein expressed and localized to the plasma membrane of gametes and ookinetes in Plasmodium berghei, is an excellent TBV candidate. Here, we evaluated the TB potential of...
Saved in:
Main Author: | Bai J. |
---|---|
Other Authors: | Mahidol University |
Format: | Article |
Published: |
2023
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/81687 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
STUDIES ON THE TRANSPLACENTAL TRANSMISSION OF PLASMODIUM BERGHEI BERGHEI
by: CHEZIAN SOMASUNDARAM
Published: (2019) -
Evaluation of two Plasmodium vivax sexual stage antigens as transmission-blocking vaccine candidates
by: Yongzhe Zhang, et al.
Published: (2022) -
Evaluation of Plasmodium vivax HAP2 as a transmission-blocking vaccine candidate
by: Yue Qiu, et al.
Published: (2020) -
Plasmodium vivax transmission-blocking vaccines: Progress, challenges and innovation
by: Mayumi Tachibana, et al.
Published: (2022) -
Plasmodium vivax transmission-blocking vaccines: Progress, challenges and innovation
by: Tachibana M.
Published: (2023)